Hjem › Ulcerøs colitis › Alabama
Ulcerøs colitis kliniske forsøg i Alabama
7 studier for Ulcerøs colitis søger deltagere på steder i Alabama.
Byer i Alabama
Officiel studietekst (engelsk)
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Digestive Health Specialists /ID# 280827, Dothan
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 2. okt. 2026 · NCT07697456A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Gastro Health, Birmingham
- East View Medical Research, Mobile
RekruttererFase 4
Alder 18 til 80 · Alle køn · Opdateret 30. sep. 2026 · NCT06581328Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Digestive Health Specialists, Dothan
RekruttererFase 3
Alder 18 til 70 · Alle køn · Opdateret 24. sep. 2026 · NCT06937086A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
- Digestive Health Specialsits, Dothan
RekruttererFase 4
Alder 18 til 65 · Alle køn · Opdateret 21. sep. 2026 · NCT06095128A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- University of South Alabama (USA) Physicians Group, Mobile
RekruttererFase 3
Alder 2 og opefter · Alle køn · Opdateret 7. maj 2026 · NCT05442567A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, Birmingham
RekruttererFase 2
Alder 18 til 80 · Alle køn · Opdateret 12. mar. 2026 · NCT07113522Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC)
- University of Alabama Medicine, Birmingham
Rekrutterer
Alder 18 til 85 · Alle køn · Opdateret 8. jan. 2026 · NCT05987852Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.